Iterum Therapeutics PLC
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ITRM
Iterum Therapeutics plc is a clinical-stage pharmaceutical company. The Company develops differentiated anti-infectives. It offers ORLYNVAH (sulopenem in an oral tablet formulation) medicine, which is an oral penem antibiotic for the treatment of uncomplicated urinary tract infections caused by the designated microorganisms Escherichia coli, Klebsiella pneumoniae, or Proteus mirabilis in adult women. Sulopenem is a potent, thiopenem antibiotic delivered intravenously which is active against bacteria that belong to the group of organisms known as gram-negatives and cause urinary tract and intra-abdominal infections. The Company operates as a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.
Find out what a historical investment in Iterum Therapeutics PLC would be worth today using our ITRM stock calculator.
$21.22M
-
0.00%
575.39K
$0.42
$0.38
$0.40
$2.10
$0.36
Ready to start your investing journey with Stake?
Open an accountITRM FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ITRM
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ITRM
on Stake
Buy ITRM from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ITRM from only US$10 with fractional shares
